Stock Price Quote

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE26084.75-13 (-0.05 %)
PREV CLOSE ( ) 26097.75
OPEN PRICE ( ) 26000.00
BID PRICE (QTY) 26062.25 (1)
OFFER PRICE (QTY) 26117.35 (1)
VOLUME 159
TODAY'S LOW / HIGH ( )25880.85 26137.95
52 WK LOW / HIGH ( )21451.5 29628.15
NSE26160.75-8.3 (-0.03 %)
PREV CLOSE( ) 26169.05
OPEN PRICE ( ) 26200.05
BID PRICE (QTY) 26161.20 (1)
OFFER PRICE (QTY) 26181.00 (2)
VOLUME 3696
TODAY'S LOW / HIGH( ) 25850.00 26200.10
52 WK LOW / HIGH ( )21450.1 29638.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-08 1944
Management Info
Munir Shaikh - Chairman - Managing Director
Registered Office

Address Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone 022-50461000 / 2000 / 67978888

Email webmasterindia@abbott.com / investorrelations.india@abbott.com

Website www.abbott.co.in

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

09May Appointment of Statutory Auditors
Inter alia, approved:- 1. The Board of Directors re comm ended payment..
12Apr Abbott India informs about appointment
In compliance with Regulation 30 of the Securities and Exchange Board of..
27Mar Abbott India informs about newspaper a
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
19Mar Abbott India informs about resignation
With reference to its earlier communication dated December 19, 2023, whe..
15Mar Abbott India informs about change in s
Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Sche..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit2870.612012.2
Gross Profit 3896.8 16177.5
Operating Profit 4106.817013.7
Net Sales 14386.358489.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Chandra Bhagat Pharm (BSE)
peergroup  120.00 (8.25%)
M.Cap ( in Cr)90.54
Supriya Lifescience (BSE)
peergroup  353.30 (1.76%)
M.Cap ( in Cr)2773.84
Innova Captab (BSE)
peergroup  492.90 (0.72%)
M.Cap ( in Cr)2820.04
Lactose India (BSE)
peergroup  142.25 (2.15%)
M.Cap ( in Cr)184.05
Bal Pharma (BSE)
peergroup  122.94 (2.30%)
M.Cap ( in Cr)195.45

Shareholding Pattern

PROMOTERS 74.99%
MUTUAL FUNDS/UTI 7.57%
NON-INSTITUTION 15.92%
FI/BANKS/INSURANCE 1.23%
GOVERNMENT 0%
FII 0%

About

no data found

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.